NASDAQ:RARE | EBITDA Margin | Ultragenyx Pharmaceutical Inc.

Complete source-backed ebitda margin history.

Available history
2016-12-31 to 2026-03-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2026-03-31-118.38%
2025-12-31-50.41%
2025-03-31-96.40%
2024-12-31-68.49%
2024-03-31-143.80%
2023-12-31-89.37%
2023-03-31-148.13%
2022-12-31-136.11%
2022-03-31-165.81%
2021-12-31-118.76%
2021-03-31-103.83%
2020-12-31-101.54%
2020-03-31-324.47%
2019-12-31-259.27%
2019-03-31-534.31%
2018-12-31-537.46%
2018-03-31-846.00%
2017-12-31-3907.21%

Annual EBITDA Margin

DateEBITDA Margin
2025-12-31-74.29%
2024-12-31-89.29%
2023-12-31-125.12%
2022-12-31-173.59%
2021-12-31-104.86%
2020-12-31-117.28%
2019-12-31-400.75%
2018-12-31-683.24%
2017-12-31-12370.48%
2016-12-31-183896.99%